Garmin® Health and ActiGraph™ collaborate on wearable solutions for clinical trials

OLATHE, Kan.–(BUSINESS WIRE)–Garmin International, Inc., a unit of Garmin Ltd. (NASDAQ: GRMN), today
announced a collaboration with ActiGraph to explore creation of
innovative health and activity monitoring solutions that would utilize
Garmin wearables and ActiGraph‘s CentrePoint data analytics platform for
academic research, clinical trials, and remote patient monitoring.

ActiGraph, a global leader in medical-grade activity and sleep
monitoring solutions for the scientific community, provides wearable
accelerometry monitors and a robust software technology platform that
together form the most comprehensive data monitoring, analysis, and
management solution in the industry. Considered the gold standard in
objective, physical activity measurement, ActiGraph monitors are the
most widely used and extensively validated devices of their kind, with
clients at more than 1,500 pharmaceutical, academic, and scientific
institutions in over 85 countries.

“Garmin Health is excited to work with a globally recognized company
like ActiGraph that shares an engineering commitment to pioneer
high-quality solutions that can be trusted by the scientific community
and pharmaceutical market,” said Travis Johnson, Garmin Health global
product lead. “Combining the sensor data from Garmin wearables with the
data capture and analytical expertise of the ActiGraph platform creates
a powerful solution for many different patient monitoring applications.”

“ActiGraph is excited to work with an innovative company like Garmin,”
said Jeremy Wyatt, ActiGraph chief technology officer and senior vice
president of product development. “Garmin wearables produce
high-resolution, accurate data streams that are ideal for scientific
analysis and can provide additional, novel endpoints to the ActiGraph
software platform. What’s more, the long battery life and ergonomic
design of Garmin’s wearables means study participants can comfortably
wear the devices for extended periods, leading to improved program
adherence and study results.”

The future of wearables as important health and medical tools is rapidly
evolving. Garmin is committed to the development of wearables that can
lead to the detection of serious health conditions, and they also play
an important role in the development of both traditional and digital
therapeutics. Collaborating with ActiGraph on solutions for researchers
will accelerate these developments and ultimately improve health
outcomes and everyday life for many people.

The ever-expanding Garmin fitness segment develops technologies to
enhance and promote healthy and active lifestyles. Garmin Health
provides enterprise solutions that leverage Garmin wearables and the
high-quality sensor data they produce for applications in the corporate
wellness, population health, and patient monitoring markets.

About Garmin International, Inc.

Garmin International, Inc., is a subsidiary of Garmin Ltd. (Nasdaq:
GRMN). Garmin Ltd. is incorporated in Switzerland, and its principal
subsidiaries are located in the United States, Taiwan and the United
Kingdom. Garmin is registered trademarks of Garmin Ltd. All rights

About ActiGraph

ActiGraph is a leading provider of medical-grade physical activity and
sleep monitoring solutions for the global scientific community.
ActiGraph’s wearable actigraphy monitors and robust analytics platform
have been widely used to quantify human movement in academic and
population health research for nearly two decades. In recent years, the
company’s monitoring solutions have been steadily adopted by biopharma
and life sciences organizations seeking to capture real-world objective
outcomes related to physical activity, mobility, and sleep behavior for
patients enrolled in clinical trials.

Notice on Forward-Looking Statements:

This release includes forward-looking statements regarding Garmin Ltd.
and its business. Such statements are based on management’s current
expectations. The forward-looking events and circumstances discussed in
this release may not occur and actual results could differ materially as
a result of known and unknown risk factors and uncertainties affecting
Garmin, including, but not limited to, the risk factors listed in the
Annual Report on Form 10-K for the year ended December 30, 2017, filed
by Garmin with the Securities and Exchange Commission (Commission file
number 0-31983). A copy of such Form 10-K is available at
No forward-looking statement can be guaranteed. Forward-looking
statements speak only as of the date on which they are made and Garmin
undertakes no obligation to publicly update or revise any
forward-looking statement, whether as a result of new information,
future events, or otherwise.



Garmin International Inc. Carly Hysell913/397-8200 [email protected]